Media

Today, Congresswoman Rosa DeLauro (CT-03) released a statement in response to the U.S. Supreme Court’s ruling on Garland v. Cargill, a case related to the ban of bump stocks, which enable semi-automatic firearms to function like automatic firearms by firing cartridges continuously.

Today, Congresswoman Rosa DeLauro (CT-03) released a statement in response to the U.S. Supreme Court’s ruling on FDA v. Alliance for Hippocratic Medicine, a case related to access to mifepristone tablets – a drug used for terminating pregnancies.

Today, Congresswoman Rosa DeLauro (CT-03) released a statement in response to the Health and Human Services Office of Inspector General (OIG) releasing its report on Food and Drug Administration’s (FDA) handling of the Abbott powdered infant formula recall.

Today, Congresswoman Rosa DeLauro (CT-03) released a statement on a proclamation issued by President Biden to strengthen border security and limit unlawful border crossings:

Congresswoman Rosa DeLauro (CT-03) issued a statement on the ongoing invasion of Rafah by the government of Israel:

Today, Congresswoman Rosa DeLauro (CT-03) reintroduced the Physician Education for Fistula Treatment Act. May 23rd is the International Day to End Obstetric Fistula, a day to raise awareness about obstetric fistula which affects an estimated 500,000 women and girls worldwide each year.

Congresswoman Rosa DeLauro released a statement after voting in favor of the Antisemitism Awareness Act, legislation that requires the Department of Education to adopt the International Holocaust Remembrance Alliance (IHRA) definition of antisemitism when determining if an action violates Title VI of the Civil Rights Act of 1964.  

Today, Congresswoman Rosa DeLauro (CT-03) released a statement in response to recommendations issued by the U.S. Preventive Services Task Force regarding breast cancer.